Annual CFI
$0.00
+$355.00 K+100.00%
31 December 2023
Summary:
TherapeuticsMD annual cash flow from investing activities is currently $0.00, with the most recent change of +$355.00 thousand (+100.00%) on 31 December 2023. During the last 3 years, it has risen by +$1.60 million (+100.00%). TXMD annual CFI is now -100.00% below its all-time high of $141.30 thousand, reached on 31 December 1996.TXMD Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
N/A
30 September 2024
Summary:
TherapeuticsMD quarterly cash flow from investing activities is not available.TXMD Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
N/A
30 September 2024
Summary:
TherapeuticsMD TTM cash flow from investing activities is not available.TXMD TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TXMD Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +100.0% | - | - |
| 3 y3 years | +100.0% | - | - |
| 5 y5 years | +100.0% | - | - |
TXMD Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | +100.0% | |||||
| 5 y | 5 years | +100.0% | |||||
| alltime | all time | -100.0% | +100.0% |
TherapeuticsMD Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $0.00(-100.0%) | - | - |
| Dec 2022 | -$355.00 K(-84.0%) | -$74.00 K(-1157.1%) | -$355.00 K(-80.2%) |
| Sept 2022 | - | $7000.00(-109.2%) | -$1.79 M(-9.5%) |
| June 2022 | - | -$76.00 K(-64.2%) | -$1.98 M(-0.7%) |
| Mar 2022 | - | -$212.00 K(-86.0%) | -$2.00 M(-10.2%) |
| Dec 2021 | -$2.22 M(+39.1%) | -$1.51 M(+731.9%) | -$2.22 M(+84.8%) |
| Sept 2021 | - | -$182.00 K(+104.5%) | -$1.20 M(-6.2%) |
| June 2021 | - | -$89.00 K(-79.7%) | -$1.28 M(-19.5%) |
| Mar 2021 | - | -$438.00 K(-11.3%) | -$1.59 M(-0.3%) |
| Dec 2020 | -$1.60 M(-93.3%) | -$494.00 K(+88.5%) | -$1.60 M(-92.7%) |
| Sept 2020 | - | -$262.00 K(-34.3%) | -$21.82 M(-4.6%) |
| June 2020 | - | -$399.00 K(-9.9%) | -$22.86 M(-3.4%) |
| Mar 2020 | - | -$443.00 K(-97.9%) | -$23.67 M(-0.9%) |
| Dec 2019 | -$23.89 M(+11.1%) | -$20.71 M(+1490.7%) | -$23.89 M(+520.6%) |
| Sept 2019 | - | -$1.30 M(+7.6%) | -$3.85 M(-83.2%) |
| June 2019 | - | -$1.21 M(+81.8%) | -$22.88 M(+4.1%) |
| Mar 2019 | - | -$665.90 K(-0.8%) | -$21.98 M(+2.3%) |
| Dec 2018 | -$21.50 M(+2499.2%) | -$671.20 K(-96.7%) | -$21.50 M(+1.5%) |
| Sept 2018 | - | -$20.33 M(+6430.1%) | -$21.18 M(+2213.0%) |
| June 2018 | - | -$311.40 K(+72.5%) | -$915.60 K(+5.0%) |
| Mar 2018 | - | -$180.50 K(-48.6%) | -$872.30 K(+5.5%) |
| Dec 2017 | -$827.10 K(-34.1%) | -$351.50 K(+386.8%) | -$827.10 K(-4.7%) |
| Sept 2017 | - | -$72.20 K(-73.1%) | -$867.60 K(-12.9%) |
| June 2017 | - | -$268.10 K(+98.2%) | -$995.70 K(-18.8%) |
| Mar 2017 | - | -$135.30 K(-65.5%) | -$1.23 M(-2.4%) |
| Dec 2016 | -$1.26 M(+114.8%) | -$392.00 K(+95.7%) | -$1.26 M(-4.5%) |
| Sept 2016 | - | -$200.30 K(-59.8%) | -$1.31 M(+14.0%) |
| June 2016 | - | -$498.10 K(+201.9%) | -$1.15 M(+61.8%) |
| Mar 2016 | - | -$165.00 K(-63.4%) | -$712.50 K(+21.9%) |
| Dec 2015 | -$584.40 K(-3.7%) | -$450.80 K(+1050.0%) | -$584.40 K(+13.3%) |
| Sept 2015 | - | -$39.20 K(-31.8%) | -$516.00 K(+10.3%) |
| June 2015 | - | -$57.50 K(+55.8%) | -$467.70 K(-10.5%) |
| Mar 2015 | - | -$36.90 K(-90.4%) | -$522.60 K(-13.9%) |
| Dec 2014 | -$606.80 K(+4.0%) | -$382.40 K(-4302.2%) | -$606.70 K(+15.2%) |
| Sept 2014 | - | $9100.00(-108.1%) | -$526.50 K(-5.5%) |
| June 2014 | - | -$112.40 K(-7.1%) | -$556.90 K(-7.3%) |
| Mar 2014 | - | -$121.00 K(-60.0%) | -$600.70 K(+2.9%) |
| Dec 2013 | -$583.60 K(+114.2%) | -$302.20 K(+1318.8%) | -$583.60 K(+47.1%) |
| Sept 2013 | - | -$21.30 K(-86.4%) | -$396.80 K(-4.8%) |
| June 2013 | - | -$156.20 K(+50.3%) | -$417.00 K(+25.6%) |
| Mar 2013 | - | -$103.90 K(-10.0%) | -$331.90 K(+21.8%) |
| Dec 2012 | -$272.50 K(+624.7%) | -$115.40 K(+178.1%) | -$272.50 K(+74.8%) |
| Sept 2012 | - | -$41.50 K(-41.6%) | -$155.90 K(-216.9%) |
| June 2012 | - | -$71.10 K(+59.8%) | $133.40 K(-287.4%) |
| Mar 2012 | - | -$44.50 K(-3808.3%) | -$71.20 K(+89.4%) |
| Dec 2011 | -$37.60 K(+37.7%) | $1200.00(-99.5%) | -$37.60 K(-117.1%) |
| Sept 2011 | - | $247.80 K(-189.9%) | $219.40 K(-318.5%) |
| June 2011 | - | -$275.70 K(+2429.4%) | -$100.40 K(-802.1%) |
| Mar 2011 | - | -$10.90 K(-104.2%) | $14.30 K(-152.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2010 | -$27.30 K(-96.8%) | $258.20 K(-458.6%) | -$27.30 K(-93.6%) |
| Sept 2010 | - | -$72.00 K(-55.3%) | -$426.80 K(-59.5%) |
| June 2010 | - | -$161.00 K(+206.7%) | -$1.05 M(+18.0%) |
| Mar 2010 | - | -$52.50 K(-62.8%) | -$893.80 K(+6.2%) |
| Dec 2009 | -$841.30 K(<-9900.0%) | -$141.30 K(-79.8%) | -$841.30 K(+20.2%) |
| Sept 2009 | - | -$700.00 K(<-9900.0%) | -$700.00 K(<-9900.0%) |
| Dec 2008 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sept 2008 | - | $0.00(0.0%) | $87.00 K(+90.8%) |
| June 2008 | - | $0.00(0.0%) | $45.60 K(0.0%) |
| Mar 2008 | - | $0.00(-100.0%) | $45.60 K(+100.0%) |
| Dec 2007 | $22.80 K(-58.0%) | $87.00 K(-310.1%) | $22.80 K(-120.7%) |
| Sept 2007 | - | -$41.40 K(<-9900.0%) | -$110.40 K(+509.9%) |
| June 2007 | - | $0.00(-100.0%) | -$18.10 K(-143.2%) |
| Mar 2007 | - | -$22.80 K(-50.6%) | $41.90 K(-22.7%) |
| Dec 2006 | $54.30 K(-179.4%) | -$46.20 K(-190.8%) | $54.20 K(+33.2%) |
| Sept 2006 | - | $50.90 K(-15.2%) | $40.70 K(-162.6%) |
| June 2006 | - | $60.00 K(-671.4%) | -$65.00 K(-21.3%) |
| Mar 2006 | - | -$10.50 K(-82.4%) | -$82.60 K(+20.8%) |
| Dec 2005 | -$68.40 K(-34.6%) | -$59.70 K(+8.9%) | -$68.40 K(-161.9%) |
| Sept 2005 | - | -$54.80 K(-229.2%) | $110.50 K(-223.6%) |
| June 2005 | - | $42.40 K(+1045.9%) | -$89.40 K(-44.8%) |
| Mar 2005 | - | $3700.00(-96.9%) | -$162.00 K(+55.0%) |
| Dec 2004 | -$104.60 K(-66.5%) | $119.20 K(-146.8%) | -$104.50 K(-71.7%) |
| Sept 2004 | - | -$254.70 K(+743.4%) | -$368.70 K(+195.4%) |
| June 2004 | - | -$30.20 K(-149.3%) | -$124.80 K(-31.7%) |
| Mar 2004 | - | $61.20 K(-142.2%) | -$182.80 K(-41.4%) |
| Dec 2003 | -$312.00 K(+104.6%) | -$145.00 K(+1242.6%) | -$312.00 K(+65.2%) |
| Sept 2003 | - | -$10.80 K(-87.8%) | -$188.90 K(+6.1%) |
| June 2003 | - | -$88.20 K(+29.7%) | -$178.10 K(-26.9%) |
| Mar 2003 | - | -$68.00 K(+210.5%) | -$243.50 K(+59.7%) |
| Dec 2002 | -$152.50 K(+951.7%) | -$21.90 K(<-9900.0%) | -$152.50 K(+175.8%) |
| Sept 2002 | - | $0.00(-100.0%) | -$55.30 K(-55.7%) |
| June 2002 | - | -$153.60 K(-767.8%) | -$124.90 K(-1569.4%) |
| Mar 2002 | - | $23.00 K(-69.5%) | $8500.00(-158.6%) |
| Dec 2001 | -$14.50 K(<-9900.0%) | $75.30 K(-208.2%) | -$14.50 K(-83.9%) |
| Sept 2001 | - | -$69.60 K(+244.6%) | -$89.80 K(+344.6%) |
| June 2001 | - | -$20.20 K(<-9900.0%) | -$20.20 K(<-9900.0%) |
| Mar 2001 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2000 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sept 2000 | - | $0.00(0.0%) | $8500.00(0.0%) |
| June 2000 | - | $0.00(-100.0%) | $8500.00(0.0%) |
| Dec 1999 | $8500.00(-104.3%) | $8500.00(>+9900.0%) | $8500.00(>+9900.0%) |
| Sept 1999 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 1999 | - | $0.00 | $0.00 |
| Dec 1998 | -$196.40 K(+106.7%) | - | - |
| Dec 1997 | -$95.00 K(-167.2%) | - | - |
| Dec 1996 | $141.30 K(-266.0%) | - | - |
| Dec 1995 | -$85.10 K(+14.4%) | - | - |
| Dec 1994 | -$74.40 K(+60.3%) | - | - |
| Dec 1993 | -$46.40 K | - | - |
FAQ
- What is TherapeuticsMD annual cash flow from investing activities?
- What is the all time high annual CFI for TherapeuticsMD?
- What is TherapeuticsMD annual CFI year-on-year change?
- What is the all time high quarterly CFI for TherapeuticsMD?
- What is the all time high TTM CFI for TherapeuticsMD?
What is TherapeuticsMD annual cash flow from investing activities?
The current annual CFI of TXMD is $0.00
What is the all time high annual CFI for TherapeuticsMD?
TherapeuticsMD all-time high annual cash flow from investing activities is $141.30 K
What is TherapeuticsMD annual CFI year-on-year change?
Over the past year, TXMD annual cash flow from investing activities has changed by +$355.00 K (+100.00%)
What is the all time high quarterly CFI for TherapeuticsMD?
TherapeuticsMD all-time high quarterly cash flow from investing activities is $258.20 K
What is the all time high TTM CFI for TherapeuticsMD?
TherapeuticsMD all-time high TTM cash flow from investing activities is $219.40 K